SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001401914-24-000027
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:45
Documents
6
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2024def14adefinitiveproxy.htm DEF 14A 579396
2 darebioinlinefullcolorrgbaa.jpg GRAPHIC 130914
3 darebioscienceinc_vxprxyxpb.jpg GRAPHIC 516721
4 darebioscienceinc_vxprxyxpc.jpg GRAPHIC 241390
5 image1a.jpg GRAPHIC 74670
6 imagea.jpg GRAPHIC 103294
  Complete submission text file 0001401914-24-000027.txt   2039034
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36395 | Film No.: 24883977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)